Akums Drugs & Pharmaceuticals Ltd (AKUMS) โ Announcement | 25 September 2026
Akums Drugs & Pharmaceuticals announced that its insider trading compliance window closes on October 1, 2026, ahead of the upcoming quarterly financial results announcement, restricting designated persons and their relatives from trading shares until 48 hours after results disclosure.
About Akums Drugs & Pharmaceuticals Ltd (AKUMS)
Healthcare ยท Pharmaceuticals ยท Listed on BSE
๐ก Get AI alerts when AKUMS files next
Free โข Daily 5 PM digest โข Track filings, board meetings, and corporate actions
Track AKUMS โ Free๐ก Ask AI about this filing
๐ More AKUMS filings
- ๐ด Announcement โ 23 September 2026Akums Drugs & Pharmaceuticals announced its schedule for two institutional investor meetings on Sept...
- ๐ด Announcement โ 16 September 2026Akums Drugs & Pharmaceuticals announced its participation in a scheduled investor and analyst meet o...
- ๐ด Announcement โ 3 September 2026Akums Drugs & Pharmaceuticals announced it received an ESG rating of 65 from NSE Sustainability for ...
- Announcement โ 25 August 2026Akums Drugs and Pharmaceuticals announced its participation in scheduled investor and analyst meetin...
- Announcement โ 24 August 2026Akums Drugs and Pharmaceuticals announced that its management cannot attend the scheduled Antique St...
๐ฅ Also filed on 25 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only โ not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
๐ก Get AI alerts when AKUMS files new disclosures
Track AKUMS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track AKUMS โ FreeFree account ยท 2 AI queries/day